Objective: To determine the frequency of factors leading to metabolic syndrome among non -alcoholic fatty liver disease (NAFLD) patients at a tertiary care hospital. Study Design: Descriptive cross-sectional study. Place and Duration of Study: Department of Medicine, Holy Family Hospital, Rawalpindi. Study was carried out over a period of one year from August, 2018 to July, 2019. Material and Methods: A total of 110 patients were included in this study. History was taken to rule out alcohol intake, viral and drug induce d etiology, to determine the presence of co -morbidities like obesity, type 2 diabetes mellitus, arterial hypertension and dyslipidemia. Physical examination was carried to determine the arterial blood pressure and to det...
Introduction: Nonalcoholic fatty liver disease (NAFLD) is diagnosed when >5% hepatic macrovesicular ...
Background: Non-alcoholic fatty liver disease [NAFLD] is considered as the hepatic component of Meta...
Introduction: Nonalcoholic fatty liver disease (NAFLD) is diagnosed when >5% hepatic macrovesicular ...
Objective: The aim of the study is to determine the frequency of factors leading to metabolic syndro...
Objective: The aim of the study is to determine the frequency of factors leading to metabolic syndro...
  Objective: 21st century is dedicated to noncommunicable diseases; it may be diabetes, hypertensi...
Background: Non-alcoholic fatty liver disease (NAFLD) is a benign condition, but it can go for years...
Background:The non-alcoholic fatty liver disease is increasingly being recognized as a major cause o...
Background and objective: Non‐alcoholic liver disease (NAFLD) is the common form of chronic Liver di...
AIM: Prevalence of obesity and type 2 diabetes mellitus (T2DM), both of which represent are related ...
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease; there is growing ...
Aim: The aim of the study is mainly to evaluate the association of obesity, liver enzymes, lipi...
Background: Non-alcoholic fatty liver disease and steatohepatitis now constitute the major etiology ...
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) prevalence has doubled in the last 20 years an...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)NAFLD is an heterogeneous condit...
Introduction: Nonalcoholic fatty liver disease (NAFLD) is diagnosed when >5% hepatic macrovesicular ...
Background: Non-alcoholic fatty liver disease [NAFLD] is considered as the hepatic component of Meta...
Introduction: Nonalcoholic fatty liver disease (NAFLD) is diagnosed when >5% hepatic macrovesicular ...
Objective: The aim of the study is to determine the frequency of factors leading to metabolic syndro...
Objective: The aim of the study is to determine the frequency of factors leading to metabolic syndro...
  Objective: 21st century is dedicated to noncommunicable diseases; it may be diabetes, hypertensi...
Background: Non-alcoholic fatty liver disease (NAFLD) is a benign condition, but it can go for years...
Background:The non-alcoholic fatty liver disease is increasingly being recognized as a major cause o...
Background and objective: Non‐alcoholic liver disease (NAFLD) is the common form of chronic Liver di...
AIM: Prevalence of obesity and type 2 diabetes mellitus (T2DM), both of which represent are related ...
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease; there is growing ...
Aim: The aim of the study is mainly to evaluate the association of obesity, liver enzymes, lipi...
Background: Non-alcoholic fatty liver disease and steatohepatitis now constitute the major etiology ...
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) prevalence has doubled in the last 20 years an...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)NAFLD is an heterogeneous condit...
Introduction: Nonalcoholic fatty liver disease (NAFLD) is diagnosed when >5% hepatic macrovesicular ...
Background: Non-alcoholic fatty liver disease [NAFLD] is considered as the hepatic component of Meta...
Introduction: Nonalcoholic fatty liver disease (NAFLD) is diagnosed when >5% hepatic macrovesicular ...